Zydus Lifesciences Limited (BOM:532321)
India
· Delayed Price · Currency is INR 914.45
+17.90 (2.00%)
At close: Mar 5, 2026
Zydus Lifesciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 262,432 | 232,415 | 195,474 | 172,374 | 151,099 | 144,035 | Upgrade
|
| Other Revenue | -1,539 | - | - | - | - | - | Upgrade
|
| Revenue | 260,893 | 232,415 | 195,474 | 172,374 | 151,099 | 144,035 | Upgrade
|
| Revenue Growth (YoY) | 17.27% | 18.90% | 13.40% | 14.08% | 4.90% | 1.05% | Upgrade
|
| Cost of Revenue | 72,138 | 65,384 | 63,937 | 64,707 | 56,857 | 49,434 | Upgrade
|
| Gross Profit | 188,755 | 167,031 | 131,537 | 107,667 | 94,242 | 94,601 | Upgrade
|
| Selling, General & Admin | 56,238 | 51,539 | 42,454 | 37,648 | 32,472 | 31,237 | Upgrade
|
| Other Operating Expenses | 58,202 | 46,726 | 36,047 | 34,263 | 29,873 | 29,299 | Upgrade
|
| Operating Expenses | 125,821 | 107,429 | 86,145 | 79,139 | 69,501 | 67,245 | Upgrade
|
| Operating Income | 62,934 | 59,602 | 45,392 | 28,528 | 24,741 | 27,356 | Upgrade
|
| Interest Expense | -3,201 | -935 | -440 | -1,255 | -1,144 | -1,559 | Upgrade
|
| Interest & Investment Income | 1,862 | 1,862 | 1,281 | 768 | 696 | 500 | Upgrade
|
| Earnings From Equity Investments | 923 | 578 | 1,184 | 946 | 462 | 474 | Upgrade
|
| Currency Exchange Gain (Loss) | 5,962 | 1,634 | 806 | 2,843 | 1,482 | -92 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,895 | 31 | -11 | 251 | 622 | 61 | Upgrade
|
| EBT Excluding Unusual Items | 70,375 | 62,772 | 48,212 | 32,081 | 26,859 | 26,740 | Upgrade
|
| Merger & Restructuring Charges | -245 | - | -177 | -101 | - | - | Upgrade
|
| Impairment of Goodwill | -1,350 | -1,350 | - | -5,941 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 590 | 590 | 1,385 | 596 | 874 | -187 | Upgrade
|
| Gain (Loss) on Sale of Assets | 345 | 345 | 134 | 208 | -17 | -36 | Upgrade
|
| Asset Writedown | -846 | -846 | - | - | - | -731 | Upgrade
|
| Other Unusual Items | -1,612 | -666 | -281 | - | 1,127 | -1,320 | Upgrade
|
| Pretax Income | 67,257 | 60,845 | 49,273 | 26,843 | 28,843 | 24,466 | Upgrade
|
| Income Tax Expense | 16,995 | 14,119 | 9,775 | 5,878 | 5,117 | 1,936 | Upgrade
|
| Earnings From Continuing Operations | 50,262 | 46,726 | 39,498 | 20,965 | 23,726 | 22,530 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 230 | -46 | 22,457 | -680 | Upgrade
|
| Net Income to Company | 50,262 | 46,726 | 39,728 | 20,919 | 46,183 | 21,850 | Upgrade
|
| Minority Interest in Earnings | -878 | -1,471 | -1,133 | -1,316 | -1,310 | -514 | Upgrade
|
| Net Income | 49,384 | 45,255 | 38,595 | 19,603 | 44,873 | 21,336 | Upgrade
|
| Net Income to Common | 49,384 | 45,255 | 38,595 | 19,603 | 44,873 | 21,336 | Upgrade
|
| Net Income Growth | 8.85% | 17.26% | 96.88% | -56.31% | 110.32% | 81.34% | Upgrade
|
| Shares Outstanding (Basic) | 1,006 | 1,006 | 1,012 | 1,016 | 1,024 | 1,024 | Upgrade
|
| Shares Outstanding (Diluted) | 1,006 | 1,006 | 1,012 | 1,016 | 1,024 | 1,024 | Upgrade
|
| Shares Change (YoY) | -0.11% | -0.56% | -0.37% | -0.79% | - | - | Upgrade
|
| EPS (Basic) | 49.07 | 44.97 | 38.14 | 19.30 | 43.83 | 20.84 | Upgrade
|
| EPS (Diluted) | 49.07 | 44.97 | 38.14 | 19.30 | 43.83 | 20.84 | Upgrade
|
| EPS Growth | 8.97% | 17.92% | 97.61% | -55.97% | 110.32% | 81.34% | Upgrade
|
| Free Cash Flow | - | 50,641 | 22,897 | 16,579 | 9,019 | 24,399 | Upgrade
|
| Free Cash Flow Per Share | - | 50.33 | 22.63 | 16.32 | 8.81 | 23.83 | Upgrade
|
| Dividend Per Share | - | 11.000 | 3.000 | 6.000 | 2.500 | 3.500 | Upgrade
|
| Dividend Growth | - | 266.67% | -50.00% | 140.00% | -28.57% | - | Upgrade
|
| Gross Margin | 72.35% | 71.87% | 67.29% | 62.46% | 62.37% | 65.68% | Upgrade
|
| Operating Margin | 24.12% | 25.64% | 23.22% | 16.55% | 16.37% | 18.99% | Upgrade
|
| Profit Margin | 18.93% | 19.47% | 19.74% | 11.37% | 29.70% | 14.81% | Upgrade
|
| Free Cash Flow Margin | - | 21.79% | 11.71% | 9.62% | 5.97% | 16.94% | Upgrade
|
| EBITDA | 72,776 | 68,303 | 52,572 | 35,344 | 31,695 | 34,152 | Upgrade
|
| EBITDA Margin | 27.89% | 29.39% | 26.90% | 20.50% | 20.98% | 23.71% | Upgrade
|
| D&A For EBITDA | 9,842 | 8,701 | 7,180 | 6,816 | 6,954 | 6,796 | Upgrade
|
| EBIT | 62,934 | 59,602 | 45,392 | 28,528 | 24,741 | 27,356 | Upgrade
|
| EBIT Margin | 24.12% | 25.64% | 23.22% | 16.55% | 16.37% | 18.99% | Upgrade
|
| Effective Tax Rate | 25.27% | 23.21% | 19.84% | 21.90% | 17.74% | 7.91% | Upgrade
|
| Revenue as Reported | 265,452 | 235,110 | 198,315 | 174,240 | 153,346 | 144,491 | Upgrade
|
| Advertising Expenses | - | 3,368 | 2,957 | 2,573 | 2,514 | 2,543 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.